Navigation Links
Human Genome Sciences to Host July 20 Conference Call to Discuss Top-Line Phase 3 Results for Benlysta(TM) (Formerly Lymphostat-B(R)) in Systemic Lupus Erythematosus
Date:7/1/2009

ROCKVILLE, Maryland, July 1 /PRNewswire-USNewswire/ -- Human Genome Sciences, Inc. (Nasdaq: HGSI) today announced that it expects to have top-line results available on Monday, July 20, from BLISS-52, the first of two pivotal Phase 3 clinical trials of BENLYSTA(TM) (belimumab, formerly LymphoStat-B(R)) in systemic lupus erythematosus (SLE).

(Logo: http://www.newscom.com/cgi-bin/prnh/20080416/HGSLOGO )

Senior management will host a conference call to discuss the results on Monday, July 20, 2009 at 8:15 AM Eastern. The BLISS-52 data will be submitted for full presentation at an appropriate scientific meeting.

Investors may listen to the call by dialing 888-632-5010 or 913-312-0402, passcode 8364417, five to 10 minutes before the start of the call. A replay of the conference call will be available within a few hours after the call ends. Investors may listen to the replay by dialing 888-203-1112 or 719-457-0820, confirmation code 8364417.

This conference call also will be webcast and may be accessed at www.hgsi.com. Investors interested in listening to the live webcast should log on before the conference call begins in order to download any software required. The archive of the conference call will remain available for several days.

The mission of HGS is to apply great science and great medicine to bring innovative drugs to patients with unmet medical needs.

HGS, Human Genome Sciences, BENLYSTA and LymphoStat-B are trademarks of Human Genome Sciences, Inc.

Safe Harbor Statement

This announcement contain
'/>"/>

SOURCE Human Genome Sciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. PROLOR Biotech Awarded Two U.S. Patents for Its Longer-Acting Human Growth Hormone and Longer-Acting Erythropoietin
2. Fruit fly steps in to fight human disease
3. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Piper Jaffray Conference
4. Human Genome Sciences Announces Completion of Enrollment in Phase 2b Monthly-Dosing Trial of Albuferon(R)
5. Assessment of safety and efficacy of human embryonic stem cell therapy
6. Human Genome Sciences Reports Positive Long-Term Data for BENLYSTA(TM) (Formerly LymphoStat-B(R)) in Patients With Active Systemic Lupus Erythematosus
7. Printing New Organs: Foundation Funds Medical Technology That Replicates Human Tissue
8. New MIT radio chip mimics human ear
9. deCODE Study Shows Complex Interplay of the Human Biological Clock With Height, Weight and Disease
10. Human Genome Sciences and Novozymes Announce Amendment to Albumin Fusion License Agreement
11. Human Genome Sciences Announces First Quarter 2009 Financial Results and Key Developments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... THOUSAND OAKS, Calif., Dec. 14 Array ... Inc.(Nasdaq: AMGN ) today announced that they ... rights to Array,s small-molecule glucokinase activator program, including ... clinical trial in patients with Type 2 diabetes. ... agreement, Array will receive an upfront payment of ...
(Date:12/14/2009)... The third edition of Infusion Nursing: ... by the Infusion Nurses Society (INS), includes Totect(®), ... Anthracyclines are a group of chemotherapy medications including ... used in the treatment of various types of ... According to the INS publication: "In September 2007, ...
(Date:12/14/2009)... 14 Decision Resources, one of the ... and healthcare issues, finds that, owing to the ... drug market will increase more than sevenfold from ... 2018 in the United States, France, Germany, Italy, ... new Pharmacor report entitled Atrial Fibrillation ...
(Date:12/11/2009)... 11 Dendreon Corporation (Nasdaq: DNDN ... previously announced public offering have exercised in full ... of common stock at the public offering price ... the option increases the size of the offering ... stock. Dendreon expects to receive net proceeds ...
Breaking Biology Technology:Array BioPharma and Amgen Partner in Type 2 Diabetes 2Array BioPharma and Amgen Partner in Type 2 Diabetes 3Array BioPharma and Amgen Partner in Type 2 Diabetes 4Array BioPharma and Amgen Partner in Type 2 Diabetes 5Array BioPharma and Amgen Partner in Type 2 Diabetes 6Array BioPharma and Amgen Partner in Type 2 Diabetes 7Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 2Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 3Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 4Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 5The Atrial Fibrillation Drug Market Will Increase More Than Sevenfold, from $790 Million in 2008 to $6.1 Billion in 2018 2Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering 2Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering 3
... (NYSE: CRY ),a biomaterials, medical device and ... an exclusive three-year agreement with,Minneapolis-based Medafor, Inc. Under ... polysaccharide hemostatic agent for use in,cardiac and vascular ... and,general surgery, other than orthopaedic and ear, nose ...
... Pharmaceuticals,Inc. (NASDAQ: ANPI , TSX: ANP), ... today announced that it has received 510(k),clearance ... (FDA) to market its,innovative 5-Fluorouracil-coated (5-FU) Central ... "The 5-FU CVC represents our first drug-eluting ...
... Company plans to launch product immediately, NATICK, ... BSX ) today announced that it has received ... coronary stent,system in Canada. The Company reported that ... regulates pharmaceutical,drugs and medical devices, has approved its ...
Other Biology Technology:CryoLife to Distribute FDA-approved Hemostatic Agent Under Private Label 2CryoLife to Distribute FDA-approved Hemostatic Agent Under Private Label 3CryoLife to Distribute FDA-approved Hemostatic Agent Under Private Label 4CryoLife to Distribute FDA-approved Hemostatic Agent Under Private Label 5Angiotech's novel 5-FU Central Venous Catheter receives FDA 510(k) clearance 2Angiotech's novel 5-FU Central Venous Catheter receives FDA 510(k) clearance 3Angiotech's novel 5-FU Central Venous Catheter receives FDA 510(k) clearance 4Angiotech's novel 5-FU Central Venous Catheter receives FDA 510(k) clearance 5Boston Scientific Receives Canadian Approval for TAXUS(R) Liberte(R) Stent System 2Boston Scientific Receives Canadian Approval for TAXUS(R) Liberte(R) Stent System 3
(Date:12/13/2009)... associated with the health of the human lung. The ... 63 centres in Europe and Australia sheds new light ... new findings provide hope for better treatment for lung ... In the past it has been difficult to develop ... health of the lung are not completely understood. It,s ...
(Date:12/11/2009)... the global "green" trend, educators worldwide are ... enhance students, science knowledge. Studies have revealed ... raises not just science scoresenvironmental-based lessons can ... subject areas. Naturally, educators are interested in ... lessons into the classroom in hopes of ...
(Date:12/11/2009)... FORT COLLINS, COWild Malus orientalis species of wild ... applesare native to the Middle East and Central Asia. ... M. orientalis varieties from Georgia and Armenia ... narrows the large population and establishes a core collection ... to the breeding and research communities. , To identify ...
Breaking Biology News(10 mins):New genes for lung disease discovered 2Students learn environmental stewardship, improve science scores 2Understanding apples' ancestors 2Nevada Burning Man Festival Sees Giant Aerial Marijuana Bud Banner That Protests Hydroponics Hijacking 13856 1Nevada Burning Man Festival Sees Giant Aerial Marijuana Bud Banner That Protests Hydroponics Hijacking 13856 2Nevada Burning Man Festival Sees Giant Aerial Marijuana Bud Banner That Protests Hydroponics Hijacking 13856 3Time to tap climate change combating potential of the worlds ecosystems 9790 1Time to tap climate change combating potential of the worlds ecosystems 9790 2Time to tap climate change combating potential of the worlds ecosystems 9790 3Time to tap climate change combating potential of the worlds ecosystems 9790 4Time to tap climate change combating potential of the worlds ecosystems 9790 5HCC Life Insurance Company Renames Short Term Medical Insurance 56237 1HCC Life Insurance Company Renames Short Term Medical Insurance 56237 2
... for Special Surgery have identified two new targets for drugs ... drugs that hone in on these targets, patients may be ... , The study identifies very good therapeutic targets, and what ... Lionel Ivashkiv, M.D., director of Basic Research at Hospital for ...
... Carbon emissions from human activities are not just heating ... This could soon be fatal to coral reefs, ... economies of many coastal communities. Scientists from the ... if current carbon dioxide emission trends continue, by mid-century ...
... Queens University environmental scientist will head a new international ... snake-like fish considered worldwide to be a food delicacy ... , Biology professor Peter Hodson and his team of ... Sciences and Engineering Research Council (NSERC) to solve the ...
Other Biology News:New approach for attacking lupus identified 2Coral reefs unlikely to survive in acid oceans 2Where have all the lake eels gone? Queen's prof asks 2
... In the six short years since publication ... John Walkers widely acclaimed Protein Protocols Handbook, ... in protein biochemistry. In recognition of the ... the rapid evolution of new methodologies directed ...
... silencing experiments often call for critical, ... Transfection Agent refines siRNA transfection protocols ... lipid-based formulation can be used to ... are subcultured without increased cytotoxicity. ...
Kit for BASE20/50 dual control unit, includes mounting plate, HOLDER50T, HEATERPAD50, SRTDX temperature probe(s)....
... The CHEMICON® CaspaTag™ Pan-Caspase In Situ ... detection of active caspases in cells undergoing ... only. Not for use in diagnostic or ... Assay Kits use a novel approach to ...
Biology Products: